Healthcare Reading Tea Leaves

https://www.semafor.com/newsletter/11/05/2026/semafor-healthcare-reading-tea-leaves

It’s healthcare costs, stupid. Washington is still collecting itself after a blue tsunami delivered House and Senate majorities on Tuesday — but Democrats are already gearing up a healthcare agenda to goad President Donald Trump into vetoing policies voters support.

Easy initial targets include rolling back Medicaid cuts and restoring Affordable Care Act enhanced tax credits that the GOP allowed to lapse, two policies hitting household budgets as healthcare premiums spike. But lawmakers will need to figure out how to pay for those efforts, and California voters demonstrated this week that even in a blue wave, raising taxes on wealthy Americans is challenging.

Other legislative pushes could preview what Democrats run on in 2028.

Progressives will inevitably demand a House vote on a Medicare for All bill, even if Rep. Hakeem Jeffries, the expected House speaker, would prefer to first have a “family conversation.” Trump’s propensity to support most-favored-nation drug pricing legislation could mean Democrats could attempt to codify paying what other wealthy nations offer for drugs.

“Democrats and President Trump talk similarly about addressing drug prices, so there may be opportunities for a strange-bedfellows kind of deal,” said Larry Levitt, who will become the CEO of KFF in January.

Sen. Bernie Sanders, I-Vt., will try to use his likely perch atop the Senate Health Committee to add dental, vision, and hearing coverage to Medicare. And expect a fight over whether to reauthorize user fees that fund roughly half the FDA — legislation that pharma considers must-pass and that Sanders has opposed for decades.

Of course there’ll be a contingent of Democratic lawmakers intent on using this moment to drag health insurer and drugmaker executives before Congress and slow-roll Trump nominees in open roles atop the FDA and HHS.

But the real opportunity for Democrats is to lay out what they will do if they take control of the presidency.

Democrats put healthcare at the center of their “affordability” message in key races. Democratic candidates, party committees, and outside groups spent a combined $226 million on healthcare-related TV ads supporting Democrats in competitive House and Senate races — dwarfing all other issues, including Donald Trump ($151 million), inflation ($141 million), and taxes ($185 million), according to an analysis of AdImpact data by the nonpartisan Cook Political Report.

Democrats sought to tie the 2025 Republican tax bill, which cut Medicaid and allowed subsidies for Affordable Care Act premiums to expire, to voter worries about rising healthcare costs as they pressed their affordability agenda. Democrats used a similar playbook in 2018, winning control of the House on a message of protecting the ACA from repeal.

Voters have historically trusted Democrats more than Republicans on healthcare. A recent Conference Board survey found Democrats held an 18-point advantage over Republicans on the question of healthcare affordability. NBC found Democrats held a 22-point advantage on “handling healthcare.”

This week’s blue wave wiped out Republican policymakers who’d been vying to define the party’s health agenda.

Sen. Roger Marshall, R-Kansas, a physician and founder of the MAHA Caucus, lost to Democrat Adam Hamilton on Tuesday. (Hamilton aired ads featuring patients who Marshall sued for unpaid medical bills.) Marshall was arguably the strongest ally of HHS Secretary Robert F. Kennedy, Jr. in the Senate. He was also in contention to become the top Republican on the powerful Senate health committee, where he could have prioritized MAHA legislation and oversight priorities if Republicans had retained Senate control.

Sen. Susan Collins, R-Maine, who was defeated this week, and Sen. Bill Cassidy, R-La., who lost a primary to a Trump-backed candidate this spring, are both Kennedy critics who led key health-related committees. Collins, the chair of the Appropriations Committee, protected funding at the NIH and CDC as the White House pushed for further cuts over the last two years. Cassidy, a physician, chaired the health committee, where he regularly challenged Trump nominees during nomination hearings. We reported earlier this year that Sen. Josh Hawley, R-Mo., may emerge the frontrunner for the top Republican spot on the health panel, as other contenders may prefer to take top GOP seats on other committees.

Reps. Mariannette Miller-Meeks, R-Iowa, and Richard Hudson, R-N.C., also both lost reelection, and their absences will erode the Republican bench on the House Energy and Commerce Committee in the next Congress.

Democrats will have a pediatrician in the Senate after Annie Andrews emerged victorious in South Carolina. Andrews ran on a detailed, wonky healthcare platform that includes increasing scrutiny of hospital mergers, setting site-neutral Medicare payments to standardize reimbursement, reforming Medicare Advantage payments, and replacing prior authorization with a new system.

Other new Democratic faces like Michigan Sen.-elect Abdul El-Sayed, an epidemiologist and former Detroit health director, and Troy Jackson of Maine, a logger-turned-politician, campaigned on Medicare for All. El-Sayed and Jackson were two of the only Democrats in competitive states to run on it. Americans increasingly support the concept of a single-payer system, long championed by the Democratic Party’s progressive wing: In October, 66% of respondents told KFF they supported Medicare for All, up from 53% six years ago. But when told such a program may require paying higher taxes, support dropped to 35%.

State healthcare ballot initiatives tested the public’s mood on abortion rights, Medicaid and new approaches to healthcare funding. Voters largely supported existing abortion rights and Medicaid programs, but were reluctant to try novel tax schemes to pay for healthcare.

In Nevada and Virginia, voters established state constitutional rights to abortion, though the measures didn’t expand access. In Missouri, voters struck down an attempt to reverse a constitutional right to abortion passed two years ago, as well as a ban on gender care for minors. Idaho voters, by contrast, rejected a measure to expand abortion access by restoring rights eliminated by a near-total ban that took effect in 2022.

In South Dakota, voters blocked a measure that would have allowed the state legislature to end funding for a Medicaid expansion approved by voters in 2022 if the federal government were to cover less than 90% of the cost.

But there are limits to what voters will support to bolster Medicaid: A tax on billionaires in California never got the traction organizers had hoped, and the measure remains far behind in the ballot count. The one-time, 5% levy was supposed to shore up existing healthcare programs and compensate for 2025 Medicaid cuts. In New Mexico and Rhode Island, meanwhile, voters endorsed a more conventional approach to funding narrower healthcare programs: They approved new bonds.

CVS unwinding its 2018 purchase of Aetna is not quite the biggest, fastest corporate M&A about-face of all time, but it’s close. The breakup, which essentially calls time on the $69 billion merger that aimed to create a healthcare giant across insurance and pharmacies, joins the top tier of corporate M&A whoopsies. It’s also a warning signal to other healthcare companies trying to read the tea leaves in Washington.

The original thesis of the CVS deal was that combining Aetna’s insurance data and CVS’ 10,000 retail pharmacies would cut costs and make care more seamless. But the savings were small relative to the deal’s price tag, and its drug-middleman business became a political drag on the retail arm. A new era of healthcare consolidation ensued, lacing together huge swaths of an uber-regulated industry into a conglomerate that critics said led to less competition and higher consumer prices.

Now, as Democrats take Congress, healthcare companies are only bracing for more regulatory scrutiny and political pressure.

“We believe, based off of where we are and how we’re performing, the businesses are best served by splitting,” CVS CEO David Joyner told The Wall Street Journal. A sign that he, indeed, is reading the room.

Campaign 2026 and Health Industry Issues: What’s Next?

Election day is finally here though final results may not be known this week due to election protocols and likely challenges in states. Per polls and commentary across the ideological spectrum, Campaign ‘26 is unprecedented for the money spent ($11.9 billion per Open Secrets), the acrimony between candidates and the blatant disinformation featured in campaigns on both sides.

Like most, I am happy it’s behind us. I value civil debate. I don’t think complex issues are explained in soundbites.  I value data that’s not cherry-picked and polls that are honest. I hate campaigns that justify any means necessary to win. I respect candidates willing to debate. And I worry that statesmanship in local, state and federal policy-setting has been sacrificed to political brinksmanship.

But while uncertainty may dog the outcome this week and potentially in the weeks ahead, there’s certainty for healthcare in the lame duck session of Congress starting next week and in states:

  • State ballot measures and fed mandates will get immediate attention by Governors and state legislatures: implementation of Medicaid work requirements in every state, abortion rights (ID, NV, VA) and referenda that address healthcare funding, school health, vaccines and more in others. CA, CO, MA, MO, NM, NC, RI, SD, WA, and WI). And governors in every Blue State and a few Red States will revisit recission of Medicaid cuts in the Big Beautiful Bill (HR1) slated to start January 1, 2027.
  • Trade associations will update their 2027 advocacy agendas and health committee profiles to prepare for the 120th Congress starting in 60 days.
  • Lobbyists and consultants will be active with their clients–trade groups, special interests, single issue advocacy 501C3s, municipalities, corporate interests et al—around (1) potential low-hanging legislative wins before the 119th Congress adjourns, (2) potential regulatory shifts in 2027 and (3) extension/expansion of their contracts with clients.
  • And the Executive Branch will sequester its key leaders across its agencies (HHS, CMS, FDA, FTC, USDA, DOJ, Commerce, et al) to protect its priorities via prepare Executive Orders, Administrative Actions, Court filings, budget appropriations and key appointments. Price transparency, competition, lower drug costs, less consolidation and stepped-up fraud, waste and abuse efforts will be its emphasis.

Looking to 2027, healthcare will be lightening rod in legislative circles and posturing by White House hopefuls in Campaign 2028. Importantly, two overarching realities will frame politics and policy discussions:

Healthcare is a major contributor to household affordability concerns. Healthcare is one of four major sources of affordability pressure on households along with housing, fuel and groceries. But unlike the other three, healthcare costs are considered unmanageable to voters because they’re often unpredictable, inexplicable and rarely transparent. It’s an issue that garners bipartisan repudiation in politics and unflattering attention to the industry’s opaque business practices.

Healthcare is seen as big business, not public service. The persona of rural hospitals, primary, behavioral and public health, nursing and home care and others is typified by many that struggle and the few that prosper. Stoked by disgruntled employees, physicians and large self-insured employers, bipartisan criticism of consolidation, vertical integration, private equity ownership, board independence, executive compensation, non-profit tax exemptions and more. Corporatization in every sector and regardless of ownership (non-profit, for-profit, or public) will be blamed and capital deployment in healthcare will reflect caution.

Healthcare will be prominent in the election post-mortem this week. Industry leaders face headwinds in the public square with voters and legislators in local, state and federal chambers. Some operate on the assumption that voters will defend the U.S. system against major changes believing it the world’s best. It’s been a safe bet historically, but the future may not be a repeat of the past.

How Democrats’ Big Win Could Reshape Health Care

https://mailchi.mp/e7ac0bb13b2c/how-democrats-big-win-could-reshape-health-care?e=ad91541e82

Some people are calling the 2026 midterms a “blue tsunami” or even a “Democratic wildfire.”

Whatever you call it, Democrats will have big majorities in the House and the Senate for the end of President Trump’s second term, which could have major implications for health policy over the next two years and beyond.

Democrats have their sights set high. They’ve pledged to repeal Republicans’ health care cuts in their first 100 hours in power — starting with restoring enhanced premium subsidies for people who buy insurance through Obamacare marketplaces and reversing nearly $1 trillion in Medicaid cuts and coverage restrictions set to take effect in January.

Achieving any of that will still require support from at least a few Republicans in Congress and President Trump. But even if they fail to roll back Republican cuts, Democrats will have far more power to influence the country’s health policy conversation, says Katie Keith, director of the Center for Health Policy and Law at Georgetown Law and a contributing editor at Health Affairs.

We spoke with Keith on Wednesday morning about Democrats’ health care affordability agenda in Washington and what the party’s strong showing at the state level could mean on issues such as abortion rights and Medicaid.

Here are some of the key takeaways from our conversation:

  • Republicans and Democrats could become “strange bedfellows” on certain health care issues — like lowering prescription drug costs or even delaying some changes to Medicaid. The size of Democrats’ margins in Congress could allow them to add pieces of their health care agenda to must-pass legislation. The question, Keith says, is, “What is the trade that could bring President Donald Trump along to agree to that?”
  • Democrats have a chance to take control of the health care agenda ahead of the 2028 presidential election — communicating to voters that “Congress hears the concerns of the American people and is doing something about it,” Keith says. She compared it to Republicans’ repeated attempts to repeal the Affordable Care Act after routing Democrats in 2010. Others have drawn comparisons to Democrats’ 2006 midterm victory, which put health care center stage in 2008 and led to the creation of Obamacare.
  • Beyond legislation, Democrats in Congress are likely to go big on oversight and transparency, Keith says, to scrutinize the actions of the Trump administration and the private health sector. For example, Congress could subpoena drug manufacturers for copies of the deals they’ve made with the White House to, among other things, charge state Medicaid programs less than they charge in other countries around the world. The specifics of these deals, which have been cut with more than two dozen drugmakers, have been kept private.
  • Democratic gains in state elections could have big implications for Medicaid. Democrats gained full control in at least five states and won a majority of races for governor and attorneys general. Keith says this red-to-blue shift could mean “a completely different approach to implementing Medicaid work requirements, eligibility and redeterminations.” New blue leadership in Wisconsin, Texas and Georgia could even, theoretically, open the door to Medicaid expansion. “The fact that you could even say maybe it’s something to look at was not something I was expecting to say the morning after [the election],” Keith says.

I hope you’ll listen to our entire episode or read the transcript.

The midterm effect: What the 2026 election could mean for public policy

On Nov. 3, voters will cast ballots that decide the balance of power in Congress and set the stage for what legislation, investigations, and rulemaking could be possible for years to come.

If the blue wave that polls predict materializes, efforts to enact and change the policy agenda will play out against a backdrop of government divided along political fault lines—with the 2028 presidential contest looming.

In this collection of essays, Brookings experts examine the implications of the upcoming election on the most significant issues facing the nation.

Democrats’ health care agenda may matter even if it stalls

The most consequential health care legislation from the next Congress may be bills that have almost no chance of becoming law.

If Democrats capture one or both chambers, health care will likely be high on their agenda. Given the parties’ divergent views on health care, major changes are unlikely while President Trump remains in office. Yet recent history shows that Democratic efforts could still shape future legislation.

House Democrats passed bills authorizing Medicare drug price negotiation in 2019 and expanding Affordable Care Act (ACA) Marketplace subsidies in 2020, despite little prospect of enactment under President Trump. Versions of both policies became law during the Biden administration. Similarly, House Republicans passed a debt ceiling bill that included Medicaid work requirements in 2023, despite President Biden’s opposition. Similar requirements became law under unified Republican control in 2025.

A Democratic agenda would likely start with reversing cuts to Medicaid and the Marketplaces enacted in 2025 and restoring enhanced Marketplace premium subsidies. But it might also include other efforts to expand or improve insurance coverage, and the appropriate scope of these efforts may spur intense intraparty debate.

Democrats may also explore cost-cutting measures, both as a way of directly lowering costs for consumers and of generating federal savings to help finance coverage improvements. This could include steps to lower hospital or drug prices or to reduce payments to Medicare Advantage plans.

Even if nothing becomes law, effort spent developing and socializing proposals might leave Democrats better positioned to enact reforms when political conditions change.

The challenges of reining in the Iran war, and prospects for broader reform

If Democrats take control of one or both chambers of the 120th Congress, they are likely to feel immense pressure to rein in the Iran war, among other controversial aspects of the Trump administration’s foreign policy. But this will be easier said than done. Trump’s continued pursuit of the war is premised on broad claims of inherent constitutional authority. Even a new majority is unlikely to have the two-thirds support necessary to override a presidential veto in order to install new legislative restrictions. Nor is cutting off funding always a politically viable alternative.

For this reason, if controlled at least in part by Democrats, the 120th Congress is likely to see more of the innovative methods the current minority has used to pressure the Trump administration into winding down the Iran war, including by withholding funding, rehabilitating dormant expedited procedures, enacting nonlegislative measures opposed to administration policies, and even exploring new litigation options. By combining these measures with newly available oversight tools and the sorts of small-bore legislative solutions (including funding limitations) that can be more readily incorporated into annual “must-pass” defense and appropriations legislation—making them difficult for the president to veto—the new majority will be able to put substantial new pressure on the Trump administration. But harder and more forward-looking limits on presidential authority will likely have to wait at least until a change in the presidency in 2029.

At that point, if Democrats secure control of both Congress and the White House—and particularly if restraint-oriented Republicans in Congress are willing to collaborate—there could be a window for foreign relations law reform not seen since the post-Vietnam era. The question will then be whether Democrats will be willing to use their undoubtedly limited time in power to engage in reforms instead of advancing their substantive policy agenda. In 2021, Democratic leaders chose to focus on the latter. But the experiences of the past few years may have changed the calculus the next time around.

Democrats are poised to investigate antitrust enforcement

If the Democrats win control of one or both chambers of Congress, expect considerable focus on antitrust. Why? First, there are serious allegations that the Trump White House worked with favored lobbyists to dictate nonmerits-based resolution of investigations and litigation over the vigorous objections of both political and career staff at the Antitrust Division of the Department of Justice (DOJ). Roger Alford, a Trump appointee who served as the division’s second-ranking official until he was fired in July 2025, laid out those allegations before the House Judiciary Subcommittee on the Administrative State, Regulatory Reform, and Antitrust. A full Democrat-chaired committee will likely want to uncover the backstories behind actions at both the DOJ and Federal Trade Commission, where the courts have questioned investigations into disfavored news organizations like Media Matters.

In addition, hearings on antitrust legislation will likely be in the offing. There is growing sentiment that antitrust enforcement against tech platforms takes too long and provides little disincentive for dominant firms to stop exploiting their gatekeeper status. That worry carries over into agentic AI. While some AI firms are seeking antitrust immunity to coordinate efforts to address rogue behavior—something they likely can do now under current antitrust law—Democrats and at least some Republicans will probably want to ensure our antitrust laws are updated to prevent a handful of AI firms from dominating this powerful new technology and foreclosing meaningful rivalry. And, if the Democrats control both the Senate and the House, there could even be AI legislation sent to Trump to face an inevitable veto.

Numerous barriers will limit what the next Congress can do

With divided party government likely, a lame duck president evincing little interest in Congress, and the 2028 presidential election already underway, prospects for major legislative change in the new 120th Congress seem slim.

Plenty of issues will be ripe in the new Congress. First in line? Any of the measures that Congress and the president fail to resolve in the upcoming lame duck session. Few expect much of the lame duck, especially if Democrats’ electoral dividends lead them to withhold support until they take the reins of one or both chambers next year. Still, other lawmakers suggest that Democrats might prefer to clear some decks before the new Congress convenes

What’s at stake for next year if not finished by year-end? Full-year funding for nearly every government agency, bipartisan permitting reform and multiyear farm bills, reauthorizing Pentagon programs (plus Trump’s demand for large increases in defense funding), and increasing the government’s borrowing limit.

Divided governments do not always stalemate. Crisis can compel politicians to act, as they did in spades in response to the 2020 global pandemic. That Congress also rewrote NAFTA and enacted several measures targeting China.

But the 120th Congress will face several barriers.

First, lawmakers will need supermajorities to overcome potential Senate filibusters. True, it’s technically possible to attempt a filibuster-proof “reconciliation” bill (like the One Big Beautiful Bill Act), but it’s been nearly two decades since Congress pursued one during divided government. Intense partisan team play and onerous federal debt will complicate negotiations. Second, whether in control of one or both chambers, Democrats will likely devote the lion’s share of their attention to investigating the conduct of the Trump administration. With little prospect of cooperation by the administration, “messaging” oversight will be the name of the game.

Finally, the 2028 race for the White House will loom large. Will legislators prefer policy accomplishments to herald on the campaign trail in 2028? Or will each party prefer to run on stalemate, blaming the other party for failure to address voters’ concerns. Either way, the road ahead will be challenging for Congress, let alone for voters demanding change.

A Democratic Congress could curb executive power

During his second term, President Trump has expanded the scope of executive power, often with the support of the Supreme Court and even when some members of the majority have expressed doubts about his approach. Other than the One Big Beautiful Bill, Congress has enacted little significant legislation, and the president has operated mostly through executive fiat.

Would Democratic victories in the forthcoming midterm elections alter this pattern? Democrats are already debating whether they should use expanded executive power for their own purposes if they regain the presidency in 2029 or instead push for a rebalancing that restores the constitutional role of Congress as a coequal branch of government.

In the short term, it is very likely that when Democrats take control of the House, they will use their powers of oversight and investigation to hold the president accountable for his policies. Administration officials will be required to testify, and some will be cited for contempt if they refuse. In addition, Rep. Hakeem Jeffries (D-N.Y.), the Democratic leader who will almost certainly become speaker if Democrats regain the majority, plans to bring to the floor a series of bills that will spell out his party’s policy priorities and underscore the differences between the parties. If Democrats win a majority in the Senate, President Trump may have a hard time getting Cabinet nominees confirmed, confirmation of lower-court judges would slow, and it would be nearly impossible to replace a retiring Supreme Court justice from the conservative bloc with a like-minded appointee.

But even more important, a Democratic-controlled Congress could challenge the president’s actions at every turn, slowing and perhaps halting the steady expansion of executive power since the beginning of President Trump’s second term and making it more difficult for a subsequent president of either party to follow in Trump’s footsteps.

Trump may favor trade battles over military confrontation

On the foreign policy front, President Donald Trump’s response to a turnover in congressional power will differ between trade and national security. On trade, I expect he will show unrelenting activism, testing the outer limits of his authority as he looks for leverage to bend other countries to his will. He will probably not shy away from congressional criticism or legal battles over his trade activism, viewing them as the price of expanding his presidential power. He also will likely view these battles as a way to shift the narrative away from congressional investigations into his actions, those of his family, and his administration. He may see value in casting himself as fighting for American workers and against entrenched interests.

On national security, Trump will likely draw down U.S. troop numbers in the Middle East and Europe, citing a reduced tempo of military operations against Iran and the results of a posture review in Europe as rationales for his decisions. Bringing troops home stands to be broadly popular with the American public, even as such decisions will likely invite scrutiny from the national security establishment. Trump is poised to shield himself against accusations of retreat and isolationism by exercising toothy power projection in Latin America under the guise of stopping narcotics trafficking and stemming immigrant flows. He will likely throw punches in directions where he does not fear counterpunches while avoiding direct confrontation with other major powers, notably China and Russia, in his final two years in office. 

Weighing the pursuit of presidential or cabinet officer impeachment

As the norm-breaking first half of the second Trump administration unfolded, several Democratic members of Congress introduced legislation calling for the president’s impeachment. Trump himself raised the specter of impeachment, saying at a Republican retreat, “If we don’t win the midterms … they’ll find a reason to impeach me. I’ll get impeached.”

Yet, as the midterm elections approach and Democratic prospects for significant electoral gains improve, impeachment remains largely absent from the party leadership’s public agenda. The biggest reason is that while impeachment requires only a majority vote, conviction requires a two-thirds vote in the Senate. Even with control of the Senate in sight, Democrats are extremely unlikely to win the two-thirds needed to convict. In addition, Trump’s declining public approval may give Democrats another reason to avoid impeachment. With the 2028 presidential election in mind, Democrats may calculate that keeping an unpopular Trump in office would be more advantageous than elevating a younger JD Vance to the presidency, which would give him an opportunity to establish his own political identity and distance himself from the administration’s record.

But that need not be the end of impeachment. Cabinet secretaries can be impeached in the same way that presidents can. Six articles of impeachment have already been filed against Defense Secretary Hegseth and one against Secretary of Health and Human Services Robert F. Kennedy Jr. In addition, Hegseth could face legal scrutiny for U.S. military strikes against alleged drug traffickers in Latin American waters, which critics argue may constitute unlawful extrajudicial killings. He is also politically vulnerable for the ongoing Iran war. Kennedy has undertaken sweeping changes that have weakened America’s public health infrastructure, and the results are apparent with the worst outbreak of measles in decades.

Odds are that if impeachment of a Cabinet officer proceeds to a trial in the Senate and picks up even a small amount of Republican support, the Cabinet officer will be forced to resign. For those who want to unseat Trump, this scenario would weaken his ability to implement what many think are impeachable policies without actually impeaching him. But perhaps most importantly, the impeachment of Cabinet officers would be a warning to Democratic and Republican presidential candidates that there is another tool that can be used to hold presidents accountable.

Financial regulation could supersede presidential action in new Congress

In financial regulation, personnel is policy. The midterms leave Democrats facing two problems. The first is the Supreme Court, which stripped most financial regulators of their political independence, so these agencies now report to the White House. The second is that Donald Trump, unlike Joe Biden, quickly put his people in place, meaning a Democratic Senate has limited leverage on personnel unless someone leaves. Expect President Trump’s team to continue promoting crypto and rolling back bank regulation with little Congress can do to stop it. Going forward, Democrats face a choice: They can defend institutions like the Federal Reserve and Federal Deposit Insurance Corporation (FDIC) even as their leaders take policy positions at odds with Democratic priorities, or they can acknowledge the court’s restructuring of government has made financial regulation an express policy lever of the White House.

Progressive Democratic chairs could force Republicans to vote on populist ideas President Trump has endorsed, such as capping credit card interest at 10%. This would put Republicans on record either against the president or against their own deregulatory philosophies. Bipartisan legislation remains possible, as it was on housing this year, even though President Trump withheld his signature. Democrats can investigate conflicts of interest around Trump’s personal crypto profits. Investigations tend to increase partisanship. Future deals will depend on whether President Trump views his legacy as being burnished by bipartisan laws or enhanced by unilateral executive action coupled with growing vitriol toward Congress.

Defense budgets, not war powers, are where Democrats can act

If the Democrats control one or both houses of Congress starting in January 2027, I expect some significant changes in national security policymaking, perhaps most notably on the defense budget and related matters.

But first, some areas where I doubt change would be significant: war powers, military reorganization, and decisions on the use of force. In each of these areas, presidents, including Trump, have generally decided that they can avert, outflank, or run over Congress. Even in the case of a modest Democratic advantage, President Trump could likely count on enough Republican support to sustain his vetoes on key issues. For example, if Congress tried to reform or rewrite the 1973 War Powers Resolution, Trump could veto such a bill—and I doubt the next Congress would do what the Senate and House did back in 1973 when they overrode President Nixon’s veto with a two-thirds majority in each chamber.

By contrast, on the core matter of defense budgeting, I expect change if the Democrats gain control (of either one or both houses). President Trump’s efforts to gain $350 billion in “mandatory” funding for the fiscal year 2027 budget, already delayed by the current Congress, would stand virtually no chance, as Congress would insist on the normal budget process and oversight (with annual “discretionary” funding that it helped manage). The Golden Dome missile defense system and Golden Battleship would get no big chunks of financial support absent detailed plans and substantial debate. Trump would probably not be able to tell the Navy how to reposition its aircraft carrier control towers and how to change the technology for its catapults. That is because, knowing of Trump’s personal and even idiosyncratic interests in these matters, Congress could insist as a condition for funding future ships that best technological and scientific practices govern how the ships are designed and built. These demands could be written into defense authorization and appropriations bills, making them binding.

This may not seem like a big deal, but normalcy, and checks and balances, need to start somewhere!

A blue wave election is not likely to create a major shift in ICE activities

As indicators of a potential blue wave begin to take shape across the political landscape, there is growing optimism that Democratic control of the House will lead to notable shifts in policy outcomes across several domestic policy domains, including immigration. Unfortunately, there might not be much change in one of the more controversial and high-profile aspects of the Trump administration’s priorities: the enforcement of deportation policy through ICE. The executive branch has a lot of power independent of Congress to enforce immigration. In fact, it was through executive orders that President Trump expanded the reach of ICE on the first day of his second term. Even if Democrats win the House, they will not be able to do much to overcome the executive power to continue ICE operations.

The main power for Congress in this area is their oversight of the federal budget, which would ordinarily allow the House to curtail operations by cutting off funds. However, Congress has used the reconciliation process in both 2025 and 2026 to appropriate nearly $240 billion for immigration purposes. This is more than enough funds to allow the Trump administration to continue their operations without much resistance from the legislative branch. One of the few prospects for Democrats eager to show voters that they are doing all they can to reform deportation policy would be clawing back unspent funds or restricting how those funds could be leveraged. Whether the new Congress will have the votes to make this happen will depend largely on how big the forecasted blue wave is in November. This is not good news for the immigrant community and the many mixed-status families living through a constant state of fear that they or their loved ones may be deported. They may have to wait until after the 2028 election to see any major changes in immigration policy.

A new Congress should address the impacts of redistricting and racial gerrymandering

The GOP’s efforts to redistrict ahead of the 2026 midterm elections will further disenfranchise Black voters, particularly in the wake of the Supreme Court’s April Louisiana v. Callais decision that delivered another blow to the already weakened Voting Rights Act (VRA). In addition to the ongoing efforts by the Trump administration to impose more stringent voter identification requirements, redistricting, which mirrors the historical process and goals of racial gerrymandering, is disproportionately impacting majority-Black and plurality-Black districts that leaned heavily Democrat in prior elections. Newly redrawn maps are taking away incumbent seats held by Black legislators, while establishing new Republican seats and thus diminishing Black political power. If Democrats can shift control in the midterms, one of their first priorities should be to enact legislation that limits, bans, or institutes objective oversight of the process.

Six states—Texas, Florida, Louisiana, Alabama, Tennessee, and North Carolina—have already split up majority- and plurality-Black districts. Nine additional states have initiated mid-decade restricting efforts. This has forced some incumbent Black legislators to run in majority-white, heavily Republican districts. Leading up to the midterms, it will be critical to thwart these increasing acts of voter suppression through more robust voter education, stronger oversight of AI’s role in enabling mis- and disinformation, and an increased number of poll watchers on Election Day, among other protections. 

However, efforts to dilute the Black vote could also backfire for the GOP as Democrat and Republican voters share similar concerns regarding the economy and cost of living. Additionally, a transfer of control to Democrats could revive debates over electoral reform. Congress could pass anti-gerrymandering legislation to avoid future partisan takeovers or require independent, bipartisan commissions as proposed in the Redistricting Reform Act of 2025. Efforts could even be bipartisan as some Republicans have called for outright bans on mid-decade changes to electoral maps. Several states have also instituted their own provisions to stop gerrymandering, and installed state-level, independent commissions that are separate from legislatures to make the process less vulnerable to partisanship. Although not currently active, Michigan has an independent citizens’ redistricting commission to review congressional and state maps.

Congressional and state oversight alone will not fully address the damage done to the Voting Rights Act, which has been pillaged and weakened by a series of Supreme Court decisions that have enabled loopholes for misinterpretation and misuse. The new Congress should make time to address these vulnerabilities in the VRA to eliminate the growing partisan influence that keeps trying to alter who gets to vote, where, and for whom, going forward.

A Democratic Congress would have limited effects on K-12 education

Even if Democrats take the House and Senate, I expect the immediate effects on K-12 education to be modest. There are a few reasons for that. First, the federal government isn’t the main stage for education policymaking; state and local governments matter more. Second, Democrats almost certainly won’t win large enough majorities to override a presidential veto, which limits what they can change from Washington. Third, it’s not all that clear what Democrats want. The party has seemed directionless on K-12 education for some time, and even the DSA platform says little about it.

Still, there would be some impacts. Congressional Democrats would throw sand in the gears of GOP policymaking. That wouldn’t necessarily stop the president’s executive actions, but it’d likely prevent another budget reconciliation package with K-12 policies that Democrats dislike. Democrats also could more forcefully resist the administration’s efforts to dismantle the Department of Education (ED)—with oversight hearings and some concrete actions. For example, they could include language in a funding bill to prohibit the interagency agreements being used to offload ED’s responsibilities to other agencies.

Perhaps the most interesting move would be Democrats passing a bill to signal their future K-12 plans should they retake the White House. One notable development is Rep. Suzanne Bonamici declaring for the race to be the top Democrat on the House Education and Workforce Committee—weeks after introducing a bill with a sprawling set of K-12 proposals. Perhaps that bill is foreshadowing Democrats’ education policy agenda for 2028.

Midterms may reshape energy policy despite little talk of it

Looking at physical reality, you’d think that 2026 would be a banner year for political attention to climate change and energy. Extreme weather, wildfires, and other perils that voters often associate with climate change are constantly in the news. Two wars entangling supplies from major oil and gas producers have sent energy prices soaring. Electricity bills are rising nearly everywhere.

Yet almost none of the midterm races will turn on energy or climate. Climate change is strikingly absent. Even Democrats inclined to support climate policy are wary of becoming too visible on a topic that voters generally don’t prioritize—despite the fact that many voters want them to say more. Despite energy being a key driver of inflation that worries voters, energy itself mostly isn’t a top campaign issue. Of the eight top issues that the Pew Center tracks for political attention, voters put energy nearly last.

Although climate and energy aren’t directly driving the upcoming elections, electoral sweeps by Democrats could have huge implications for policy. In a few states, a swing to unified Democratic control could lead to much stronger climate policies along with regulations against fossil fuels. Democrats leading one or both chambers on Capitol Hill will likely lead to investigations, retaliations, and chaos in Washington, D.C.—hardly the stuff of the stable policy signals needed on energy and climate. That looming gridlock may put a spotlight on the brief lame duck period when more bipartisan legislation might get through Congress and even be signed by the president—for energy mavens, top of that list is a new bill that would help streamline permitting and make it easier to build. With the cost of oil and refined products, such as diesel fuel, you might think that Democrats would pivot toward policies that emphasize all forms of energy, including more oil. But there is little reliable support for oil and gas expansion in the Democratic base; more likely will be investigations about the Trump administration’s diesel fuel deal with Russia and a lot more emphasis on electric vehicles, biofuels, and efficiency—all policies that are unlikely to get consent from the White House, as needed for new legislation.

One of the hottest issues this election cycle is data centers, thanks to a litany of fears that include voter worries that data center power needs will jack up prices for everyone else. Unlike practically everything else in American politics, however, data centers don’t yet have ideological fault lines. Democrats and Republicans alike are scrambling to look decisive on the matter—mainly by supporting bans. No matter who wins federal and local elections, politicians know who they should abhor. Look for more symbolic political pressure on data centers. Beyond symbolism, with D.C. locked in political gridlock, the bulk of legislative efforts may, mostly, offer a sandbox for elaborating concepts that eventually could be adopted by future governments when officeholders shuffle again after the 2028 elections.

Congress should act on AI safety before states fill the gap

One of the big challenges facing policymakers after the midterms will be addressing public concerns about AI. Polls show large majorities expressing worries about AI safety and security. With a number of news stories detailing AI agents going rogue and engaging in unauthorized or prohibited activities, there is a need for members of Congress to address these problems.

There are steps legislators can take. First is mandatory reporting of rogue actions by AI agents from large tech firms. Their tools reach millions of people and therefore are capable of harming a substantial number of individuals. Mandatory reporting would improve transparency about the scope of the problem and the types of intrusions that are most problematic.

In addition, legislators can improve legal liability for AI agents that inflict harm on consumers, businesses, or government agencies. Right now, accountability for unauthorized behavior is murky, and it’s unclear to what extent existing laws on consumer protection or business practices apply to digital tools. Clarifying liability rules would improve accountability and give tech companies clear incentives to make sure large language models are not engaging in harmful behavior.

If Congress does not move, state legislatures will act. Several states have already passed AI safety bills, and that trend will likely accelerate in the coming months. A patchwork of state rules poses an enormous challenge for tech companies, which would have a difficult time developing different models for California or New York versus Texas or Florida. It makes sense for representatives and senators to enact meaningful safeguards before conflicting policy rules proliferate at the state level.

Senate control will decide Trump’s final judicial legacy

Among presidents’ major accomplishments are significant changes in the federal judiciary’s composition. President Trump’s 231 first-term lower court judicial appointments were fewer than President Carter’s and, by a slim margin, President Biden’s.

If Republicans retain the Senate, Trump, with 308 projected appointments so far (assuming post-election confirmation of pending and announced nominees) may get the roughly 70 appointments he needs to match Presidents Reagan and President Clinton’s eight-year totals. The 22 current and announced vacancies without nominations are—at the moment—mainly in Democratic-senator states, but home-state senators’ “blue-slip” veto over district court nominees may not survive a change in Judiciary Committee leadership. And it’s anyone’s guess how many of the 55 Republican-appointed district judges and 23 circuit judges who will be eligible to retire on salary by late 2028 will do so; judges during Trump’s second term have been more reluctant than under recent predecessors to create vacancies.

A Democratic Senate, however, may be in payback mode. In their final two years, the four two-term presidents before Trump all faced opposition-controlled Senates. Until Obama, final two-year confirmations represented about 20% of total confirmations. Of Reagan’s 379 total confirmations, 84 (22%) came during his final two years. Clinton and Bush had similar percentages.

But Republicans took control of the Senate in 2015 and basically shut down judicial confirmations, resulting in only 22 confirmations—7% of all Obama confirmations.

What about the Supreme Court? If the Senate stays Republican even with a slimmer majority, look for Justice Alito to retire. If Democrats take the Senate, any vacancies will be health related, with ferocious battles over Trump’s proposed replacements either way.

Midterm winners will face pressure to rein in AI power

The backlash over data centers necessary for artificial intelligence (AI) became a major campaign topic involving everyone from local candidates to the president of the United States. What began as neighborhood concerns about local environmental and utility issues grew into a fight over AI power.

Data centers were the first place voters could clearly see the costs and risks of AI being shifted to them. The backlash exposed the corporate power dilemma of AI: that a handful of executives are making unsupervised decisions that affect everyone.

Zoning boards and state utility commissions can decide where a data center is located and who pays for its power. Some states are trying to address how AI companies behave. But only Congress can establish uniform national rules.

The challenge for the new Congress is to turn public concern into enforceable oversight of AI. The test will be whether legislators take symbolic but limited action or step up with meaningful requirements supervised by an agency with technical expertise to oversee safety evaluations, mandatory incident reporting, and protections against the abuse of market power.

The data center backlash brought the power of AI into public debate. Elected leaders must now decide whether public interest oversight or private interests will shape that power.

Why Healthcare is on Defense

Last week was business as usual for the U.S. health system as other events grabbed the lion’s share of media attention:

  • Healthcare affordability and fraud were frequent mentions as GOP candidates railed against socialized medicine and industry’s lack of competition at the 2-day ‘Trumpalooza’ event in Dallas.
  • An apocalyptic prediction released on X by Evan Hubinger, a former Anthropic alignment lead, that ‘there’s a 10% chance that RSI (recursive self-improvement) AI could kill all humans in the next decade’ prompted social media frenzy and calls for AI regulation.
  • Wars in Iran and Ukraine continued.
  • The Jewish High Holy Days began with celebrations of Rosh Hashanah Friday just after 9-11 commemorations concluded across the land.
  • And the August CPI report from the Bureau of Labor Statistics showed prices elevated as the Iran war’s energy shock spiked an inflation and prompted concern the Fed might raise interest rates at its meeting this week.

With the exception of continued commentary about the Lindsay Clancy’s mistrial and post-partum psychosis defense, the healthcare system was virtually unscathed last week. For many in healthcare, ‘out of sight, out of mind’ is OK. It allows the system to operate without distraction from unwelcome criticism—disdain for media coverage has long been the preferred modus operandi in healthcare, preferring instead its own PR, ads and behind the scenes advocacy to keep things in order to its liking. It isn’t working.

Reality: The U.S. healthcare industry is not the crown jewel of our national pride. At the opening ceremony of the 2012 Olympic Games in London, the Danny Boyle-produced tribute to the National Health Service opened the games. A similar sentiment about the U.S. system is unimaginable. In its place, a dark cloud hovers above U.S. healthcare today. It is the industry’s biggest threat. The eminent cloud burst will wrack havoc on every provider, every investor, every user and every taxpayer in the U.S. unless preparedness is taken seriously.

It did not form overnight: it’s been building for 30 years but it darker and more threatening today than ever before. Here’s why:

  • Systemic arrogance: For decades, Americans have been told our health system is the envy of the world. We’ve embraced the industry hubris—the best doctors, the best hospitals. the newest drugs, the latest technology and most modern facilities and so on. But through these decades, costs have soared while population health and longevity have declined. Better ways to diagnose, treat, and deliver services are confined to privately-funded organizers whose shareholders see financial upside, while the less lucrative needs are left to public programs and do-gooders to bootstrap. Benign neglect for educating the U.S. population about how the health system works, how it’s organized and financed, how to use it is is the system’s original sin. It was designed so that dependence on the system via doctors, insurance, hospitals and drug companies was its foundational presumption. Evidence shows done right; it works. But it hasn’t. It declares its exceptionalism while hiding its business practices to avoid scrutiny. It rejects self-care deeming it only applicable to simple problems and presumes its concept of value always keeps ‘high quality’ distant from ‘low price’ in the public psyche. And it reinforces politics and policies that keep primary care, preventive health and social services for lower income and older populations subordinate to specialty services. Ironically, its workforce—25 million strong—that’s been warning of the cloud burst loudest. They think compensation for health executives is excessive, un-deserved and contributing to the storm.
  • Corporatization-driven wealth: The industry’s business practices have created massive wealth for some. 45 of the Fortune 500 companies is an investor-owned healthcare corporation. The industry’s executive class is among the highest paid compared to peers in other industries and the differential between the industry’s working class and its senior managers is the highest of all industries. Physicians have protected the profession’s distinction as the U.S. highest paid career even after accounting for the three-fold median gap between primary care and some surgical specialties. Polls show the majority of voters aren’t sure what ‘not-for-profit’ means or if it matters. Investing in healthcare is a safe bet, especially when overall market conditions are less welcoming. That’s the secret sauce that let’s the industry maintain prominence in wealth creation for risk takers, high compensation for its managers, executives and surgeons and carry grow in the aggregate faster than GDP and household wages. It’s a business, not a calling, for its management ranks, their advisors and private funders, because corporatization produces sizeable wealth for some.
  • Blame and Shame Advocacy: The major trade associations in healthcare have contributed to the cloud’s growing intensity. Protection of their members’ interests has takes precedent over the overall sustainability of the health system. That’s understandable: their Boards expect no less from their CEOs and teams. Thus, blame and shame advocacy is a priority over coalition building for systemic reform. But voters, employers and lawmakers increasingly recognize the obvious, no trade group in healthcare effectively represents the system as a whole. Short-term wins on proposed regulations, spending authorizations and policy shifts threatening to a specific tribe are their domain. It’s for others to fix the system even as the cloud gets darker.

Political campaigns obscure facts and oversimplify solutions to complex challenges like fixing the health system. Protecting the status quo in healthcare is what its insiders want and it’s why they’re on defense. 

Paul

PS On 9/11/01, I was in Harry Jacobson’s conference room at Vanderbilt Medical Center discussing plans for our new Center for Integrative Health. The pictures of planes crashing into the World Trade Center, souls jumping to their deaths, fire-fighters running toward danger and dusty New Yorkers in zombi-like bewilderment are etched forever in my memory. It makes faith and family more meaningful and industry issues less. But in those days and after, our country seemed, if only for short while, united for a purpose. That spirit is needed for transformational change to the health system. It’s collapsing like the twin towers.

Big Insurers Are Pouring Millions Into the 2026 Midterms

Today, the Center for Health and Democracy updated the Health Insurance Influence Tracker, a publicly available tool examining how the health insurance industry uses political contributions to build power in D.C. Since 1999, the companies captured in the tracker, representing vertically-integrated for-profit corporations like UnitedHealth Group, CVS/Aetna, Cigna, and Elevance and several of the trade associations representing them, have donated more than $100 million to campaigns, including $34.9 million to current members of Congress.

For additional information and analysis on the Health Insurance Influence Tracker, see CHD’s report here.

So far in the 2026 cycle, big insurers and their largest PR and lobbying groups – AHIP, the Blue Cross Blue Shield Association (BCBSA) and the Pharmaceutical Care Management Association (PCMA), which represents insurers’ pharmacy benefit managers – have donated more than $11 million toward campaigns and campaign committees, putting them on track to exceed recent election cycle totals of $15-$17 million. What we found is that the insurance industry is donating strategically to almost every ideological group: bipartisan giving dedicated to strengthening the corporate-friendly branches of each party. With health care shaping up to be one of the biggest issues in the midterms, the industry’s involvement shows the tactics they’re using to stop reform momentum before it can take hold in a new Congress.

Total Contributions by the Health Insurance Lobby by Cycle

Grey columns are contributions through May 31 of election year. Orange columns are full-cycle contribution total.

The 2026 Cycle: What We’re Tracking So Far

Corporate health insurers have been busy in the 2026 cycle, donating $11.91 million so far, of which $5.73 million went directly to sitting members of Congress. Many of the same patterns from past cycles are repeated here; so far since the 2024 election, ten members have received more than $70,000 from the health insurance companies, all members of Congressional or party leadership.

Similarly, we can see how insurers are making strategic bets on potential future leaders or swing votes. Senators like Maggie Hassan, currently the ranking member on the Senate Finance Committee’s Subcommittee on Health, and Brian Schatz, widely reported to be seeking a higher position in Senate leadership, have seen thousands in donations this cycle, despite not being up for re-election for another two years.

Intra-Party Influence

Insurers donated heavily to incumbents in battleground races, but have also quietly poured money into primaries, wading into several intra-party fights this cycle.* Donations to more moderate candidates, like Democrats Haley Stevens in Michigan and Angie Craig in Minnesota, and Republicans John Cornyn in Texas and Kevin Hern in Oklahoma, fit with the overall party giving: moderate party groups, the New Democrat Coalition, Blue Dogs, Republican Main Street, and Tuesday Group are continuing to see disproportionate generosity from these companies.

However, even in primaries with multiple progressives, health insurers are staking out a side, which illustrates an important difference between paying lip service to progressive health policies like Medicare for All and truly fighting for them. In Colorado’s first congressional district, incumbent Representative Diana DeGette, the ranking member of the House Energy & Commerce Committee’s Subcommittee on Health, and her opponent, Melat Kiros, both say they support Medicare for All, with Representative DeGette being a longtime cosponsor of the bill. Theoretically, support of the Medicare for All Act, a bill that would prohibit private insurance from duplicating the medical and prescription coverage offered by Medicare, is an existential threat to the health insurance industry and the candidates would not garner financial or other support from their PACs. Yet in this race, as in many others, the incumbent continued to receive significant donations from insurance PACs, suggesting that the PACs see the incumbent, although they put their name on the Medicare for All bill, as someone they would be able to count on if the legislation were to gain traction. DeGette was ultimately defeated by Melat Kiros, who made rejecting all corporate PAC money a centerpiece of her campaign.

Introducing The Health Insurance Influence Tracker

Introducing The Health Insurance Influence Tracker

The Center for Health & Democracy Education Fund has released the first campaign contribution tracker covering the health insurance lobby.

Voters in Missouri’s first district faced a similar choice last week. In 2024, when Wesley Bell challenged Cori Bush for the seat, the insurance industry stayed out of the primary altogether, and only two PACs donated a joint $5,000 to Bell’s general campaign in September of that year, standard for a new member without relevant committee assignments. During this cycle, the health insurance lobby poured $31,000 from six different PACs into his campaign (former Representative Bush does not accept any corporate PAC money), a clear signal of which of the two, both co-sponsors of the Medicare for All legislation, insurers believe will least harm their bottom lines. Bell won the primary with 59% of the vote.

The Health Insurance Influence Tracker only includes incumbent members of the 119th Congress. Any analysis of challengers was conducted using Schedule B data sourced from fec.gov


Wage Rule could shake up hospital hiring

A Trump administration plan to overhaul wage levels for visa holders is jolting hospitals and long-term care facilities that are heavily reliant on foreign-born workers.

Why it matters: 

It’s the latest immigration-related policy change to loom over the health care workforce, coming after President Trump’s $100,000 H-1B visa fee and the suspension of certain immigrants’ work authorization renewals.

  • The latest move could further drive up costs for providers already struggling with staffing shortages, thin margins and growing patient demand, because many health jobs can’t be outsourced or automated.

Driving the news: 

The Department of Labor wants to change the formula for calculating what it considers “fair minimum pay” for workers on certain visas, like H-1Bs, and green card sponsorship jobs.

  • The administration says the change would make it harder for companies to use visa programs to obtain cheaper labor and undercut American workers.
  • But the rule could have an outsized effect on health systems, testing labs, nursing homes and research institutions that sponsor foreign-trained workers.
  • There’s special concern about rural health providers that rely heavily on foreign-born clinicians to fill gaps in care in underserved areas.

Critics say the change won’t adequately account for regional wage differences or experience levels.

  • They also warn a higher wage requirement will force employers to raise pay for U.S. workers to comply with labor laws — and make it unsustainable to hire foreign-born talent.

The big picture: 

The U.S. health care system is heavily dependent on a foreign-born workforce. Immigrants make up about 16% of registered nurses nationwide, per a KFF analysis.

  • They make up 28% of the U.S. long-term care workforce, KFF found.
  • “This has the potential to significantly limit the sector’s ability to provide timely and quality health care services to those in need, both now and in the future,” Dana Ritchie, associate vice president of the American Health Care Association and National Center for Assisted Living, wrote in public comments on the proposal.

Zoom in: 

Lynn Bruder, the CEO of staffing firm Nucleus Healthcare, said wage rates for visa-holding nurses on the lower end of the pay scale could jump 25% to 35% in certain markets, or from about $40 an hour to more than $50 an hour.

  • “The likely outcome is continued reliance on significantly more expensive agency staffing solutions and reduced ability for hospitals to build stable, long term workforce pipelines,” Bruder wrote in comments about the rule.

The other side: 

The Department of Labor declined to comment. But visa programs have long been criticized for suppressing wages across many industries.

  • The changes would force employers to pay an estimated $6.5 billion in additional wages and increase the average certified wage by approximately $14,000 per year, according to the proposed rule.
  • “These proposed revisions aim to better align prevailing wage levels with the wages paid to U.S. workers,” the Labor Department wrote.
  • The window for public comments on the proposal closed this week.

The bottom line: 

Health care providers say the administration is treating hospitals and nursing homes like any other employer, even though the workforce is being squeezed by an aging population and rising demand for care.

  • “Larger hospital systems may be able to absorb this increase, but you’ll see employers who are much smaller or mid-sized won’t,” Ann-Rose Johnson-Lewis, director of legal services at WorldWide HealthStaff Solutions, told Axios.
  • “You’ll see rural heath care systems not be able to absorb that. We’ll see a reduction in the workforce, fewer new hires and, ultimately, the broader economy will see the consequence of that.”

SCOTUS upholds Obamacare preventive care mandate 

https://nxslink.thehill.com/view/6230d94bc22ca34bdd8447c8o3k52.isr/aae298b7

The Supreme Court on Friday upheld a key Affordable Care Act requirement that insurance companies cover certain preventative measures recommended by an expert panel.  
Justices upheld the constitutionality of the provision in a 6-3 decision and protected access to preventative care for about 150 million Americans.   

The justices found that the secretary of the Department of Health and Human Services has the power to appoint and fire members of the U.S. Preventative Services Task Force (USPSTF).   

The cases started when a small business in Texas and some individuals filed a lawsuit against the panel’s recommendation that pre-exposure prophylaxis (PreP) for HIV be included as a preventative care service.   

They argued that covering PreP went against their religious beliefs and would “encourage homosexual behavior, intravenous drug use, and sexual activity outside of marriage between one man and one woman.”  

The plaintiffs further argued that the USPSTF mandates are unconstitutional because panel members are “inferior officers” who are not appointed by the president or confirmed by the Senate.   

While the panel is independent, they said that since their decisions impact millions of people members should be confirmed.   

A U.S. district judge in 2023 ruled that all preventative-care coverage imposed since the ACA was signed into law are invalid and a federal appeals court judge ruled in agreement last year.   

The Biden administration appealed the rulings to the Supreme Court, and the Trump administration chose to defend the law despite its long history of disparaging Obamacare.   

Though public health groups celebrated the ruling Friday, some noted another potential outcome.  

“While this is a foundational victory for patients, patients have reason to be concerned that the decision reaffirms the ability of the HHS secretary, including our current one, to control the membership and recommendations of the US Preventive Services Task Force that determines which preventive services are covered,” Anthony Wright, executive director of Families USA, said in a statement.  

“We must be vigilant to ensure Secretary Kennedy does not undo coverage of preventive services by taking actions such as his recent firing of qualified health experts from the CDC’s independent vaccine advisory committee and replacing them with his personal allies.” 

2016 Edelman Trust Barometer – Leadership in a Divided World

Click to access 2016-Edelman-Trust-Barometer-Global-_-Leadership-in-a-Divided-World1.pdf

Image result for 2016 Edelman Trust Barometer Leadership in a Divided World